Literature DB >> 11590243

mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope.

M S Kapiloff1, N Jackson, N Airhart.   

Abstract

The physical association of regulatory enzymes and ion channels at relevant intracellular sites contributes to the diversity and specificity of second messenger-mediated signal transduction in cells. mAKAP is a scaffolding protein that targets the cAMP-dependent protein kinase A and phosphodiesterase type 4D3 to the nuclear envelope of differentiated cardiac myocytes. Here we present data that the mAKAP signaling complex also includes nuclear envelope-resident ryanodine receptors and protein phosphatase 2A. The ryanodine receptor is the major cardiac ion channel responsible for calcium-induced calcium release from intracellular calcium ion stores. As demonstrated by a combination of immunohistochemistry and tissue fractionation, mAKAP is targeted specifically to the nuclear envelope, whereas the ryanodine receptor is present at both the sarcoplasmic reticulum and nuclear envelope intracellular membrane compartments. At the nuclear envelope, a subset of cardiac ryanodine receptor is bound to mAKAP and via the association with mAKAP may be regulated by protein kinase A-mediated phosphorylation. By binding protein kinase A and ryanodine receptor, mAKAP may serve as the scaffold for a cAMP- and calcium ion-sensitive signaling complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590243     DOI: 10.1242/jcs.114.17.3167

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  61 in total

Review 1.  A-kinase anchoring proteins that regulate cardiac remodeling.

Authors:  Graeme K Carnegie; Brian T Burmeister
Journal:  J Cardiovasc Pharmacol       Date:  2011-11       Impact factor: 3.105

2.  PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.

Authors:  Jennifer J Carlisle Michel; Kimberly L Dodge; Wei Wong; Nicole C Mayer; Lorene K Langeberg; John D Scott
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

Review 3.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Role of soluble adenylyl cyclase in the heart.

Authors:  Jonathan Chen; Lonny R Levin; Jochen Buck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

Review 5.  The nucleoskeleton as a genome-associated dynamic 'network of networks'.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-10-05       Impact factor: 94.444

Review 6.  Networking with AKAPs: context-dependent regulation of anchored enzymes.

Authors:  Emily J Welch; Brian W Jones; John D Scott
Journal:  Mol Interv       Date:  2010-04

Review 7.  A-kinase anchoring proteins: getting to the heart of the matter.

Authors:  John D Scott; Luis F Santana
Journal:  Circulation       Date:  2010-03-16       Impact factor: 29.690

Review 8.  Role of phospholipase Cε in physiological phosphoinositide signaling networks.

Authors:  Alan V Smrcka; Joan Heller Brown; George G Holz
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

9.  Control of cytoplasmic and nuclear protein kinase A by phosphodiesterases and phosphatases in cardiac myocytes.

Authors:  Zeineb Haj Slimane; Ibrahim Bedioune; Patrick Lechêne; Audrey Varin; Florence Lefebvre; Philippe Mateo; Valérie Domergue-Dupont; Matthias Dewenter; Wito Richter; Marco Conti; Ali El-Armouche; Jin Zhang; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  Cardiovasc Res       Date:  2014-02-18       Impact factor: 10.787

Review 10.  Calcineurin-AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends.

Authors:  Moriah Gildart; Michael S Kapiloff; Kimberly L Dodge-Kafka
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.